US-focused Pharma companies have faced multiple issues since FY16. Sun Pharmaceutical (the poster boy) is still down 30%+ from its FY15 highs, it's

US-focused Pharma companies have faced multiple issues since FY16. Sun Pharmaceutical (the poster boy) is still down 30%+ from its FY15 highs, it's